Sun Pharma is axing its R&D crowd
Advertisement
After cutting out 150 senior executives,Sun Pharmaceutical Industries is yet again axing staff even after acquiring the $3.2-billion acquisition of Ranbaxy Laboratories.
This time, around 15 staff members from research and development department would be asked to leave asSun Pharma integrates a combined staff base that's 30,000 strong.
"A thorough assessment has been made of current overlaps across the organisation. While all attempts have been made to ensure that most employees are accommodated in various positions, there will be a few who we need to help in the process of actually transitioning out of the organisation,” said company’s spokesperson.
"We have to be realistic and prepare for adverse news ahead," managing director Dilip Shanghvi told analysts on the July 20 conference call.
(Image: Reuters)
Advertisement
Advertisement
This time, around 15 staff members from research and development department would be asked to leave as
"A thorough assessment has been made of current overlaps across the organisation. While all attempts have been made to ensure that most employees are accommodated in various positions, there will be a few who we need to help in the process of actually transitioning out of the organisation,” said company’s spokesperson.
"We have to be realistic and prepare for adverse news ahead," managing director Dilip Shanghvi told analysts on the July 20 conference call.
(Image: Reuters)
Advertisement
- India's oil import bill could swell to $101-104 billion in FY25: ICRA
- Hardik's T20 WC ticket hinges on his IPL form: Sources
- India's gold demand up 8% in Jan-Mar to 136.6 tonne despite high rate
- Mahindra XUV 3XO compact SUV launched in India starting at ₹7.49 lakh
- Markets trade firm on global rally, fresh foreign fund inflows
- Nothing Phone (2a) blue edition launched
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market